Areal Méndez C, Lite Alvarez J M, Sánchez Varela J M
Servicio de Hematología y Hemoterapia del Hospital A. Marcide, Ferrol.
Sangre (Barc). 1991 Jun;36(3):237-8.
Acquired erythroblastopenia, or pure red cell aplasia, may appear as a complication of chronic lymphocytic leukaemia. This was the case in a 58 year-old man, diagnosed as having B-cell chronic lymphocytic leukaemia considered as stage C (III). He was treated initially with chlorambucil; two months after diagnosis the patient showed erythroblastopenia, being treated with chlorambucil-prednisone, cyclophosphamide-prednisone, prednisone alone, and intravenous immunoglobulins. No satisfactory response was achieved with any of these drugs. During a period of 28 weeks the patient received 41 units of packed red cells. Cyclosporin-A, at a 9 mg/Kg daily doses, was tested, a dramatic response being observed: after four weeks of such therapy the patient's haemoglobin reached 14.5 g/dL, and he needed no further transfusion since the beginning of this treatment.
获得性成红细胞减少症,即纯红细胞再生障碍,可能表现为慢性淋巴细胞白血病的一种并发症。一名58岁男性患者便是如此,他被诊断为B细胞慢性淋巴细胞白血病,处于C期(III期)。他最初接受苯丁酸氮芥治疗;诊断两个月后,患者出现成红细胞减少症,先后接受苯丁酸氮芥 - 泼尼松、环磷酰胺 - 泼尼松、单独使用泼尼松以及静脉注射免疫球蛋白治疗。使用这些药物均未取得满意疗效。在28周的时间里,该患者输注了41单位的浓缩红细胞。对患者进行了每日剂量为9毫克/千克的环孢素A试验,观察到显著疗效:经过四周的这种治疗后,患者血红蛋白达到14.5克/分升,自开始这种治疗以来他无需进一步输血。